Dashboard
Manage Tickers

BNTXBioNTech SE

Nasdaq biontech.de


$ 87.50 $ -0.68 (-0.77 %)    

Monday, 26-Aug-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.46 $ -4.66 (-0.97 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.34 (-0.24 %)
TLT $ 98.13 $ -0.25 (-0.25 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 87.51
$ 87.43 x 100
-- x --
-- - --
$ 76.53 - $ 125.83
488,124
na
20.8M
$ 0.07
$ 0.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

americans-to-access-covid-19-test-kits-for-free-as-us-government-restarts-free-at-home-program
Americans To Access COVID-19 Test Kits For...
08/26/2024 15:24:26

US households can order free COVID-19 tests starting in late September as the government reopens the program ahead of the fall ...

Core News & Articles
U.S. CDC Says For This Season Peak Hospita...
08/23/2024 15:51:38

- Press Conference

fda-approves-updated-covid-vaccines-from-pfizer-and-moderna-but-leaves-out-novavaxs-shot
FDA Approves Updated COVID Vaccines From P...
08/22/2024 18:33:49

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new...

Core News & Articles
FDA Authorizes Updated Covid-19 Vaccines B...
08/22/2024 17:30:58

- Bloomberg

Core News & Articles
WHO Official Hans Kluge Asserts Mpox Is No...
08/20/2024 17:25:45

- Reuters 

fda-set-to-approve-covid-19-vaccines-as-soon-as-this-week-stocks-etfs-to-watch
FDA Set To Approve COVID-19 Vaccines As So...
08/19/2024 16:08:30

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer ou...

fda-allows-resumption-of-biontechmedilink-therapeutics-partnered-phase-1-study-for-cancer-drug-with-lower-dose
FDA Allows Resumption Of BioNTech/MediLink...
08/19/2024 13:39:06

FDA lifts partial hold on MediLink Therapeutics' phase 1 trial for HER3-targeting ADC BNT326/YL202 in advanced lung and bre...

unveiling-12-analyst-insights-on-biontech
Unveiling 12 Analyst Insights On BioNTech
08/19/2024 13:00:30

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
08/19/2024 12:28:03

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

pfizer-biontechs-covid-19flu-combo-vaccine-fails-to-meet-key-goal-in-late-stage-study
Pfizer, BioNTech's COVID-19/Flu Combo Vacc...
08/16/2024 13:19:30

Pfizer and BioNTech report Phase 3 results for their combined mRNA vaccine against influenza and COVID-19. The trial met one of...

Core News & Articles
Pfizer And BioNTech Provide Update On mRNA...
08/16/2024 10:50:13

The trial did not meet one of its primary immunogenicity objectives of non-inferiority against the influenza B strain despite o...

jp-morgan-maintains-underweight-on-biontech-lowers-price-target-to-91
JP Morgan Maintains Underweight on BioNTec...
08/15/2024 12:07:32

JP Morgan analyst Jessica Fye maintains BioNTech (NASDAQ:BNTX) with a Underweight and lowers the price target from $94 to $91.

struggling-covid-19-vaccines-from-astrazeneca-biontechpfizer-moderna-cut-incidence-of-arterial-thromboses-that-cause-heart-attacks-strokes-british-study-shows
Struggling COVID-19 Vaccines From AstraZen...
08/13/2024 18:43:35

COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The ...

long-covid-remains-diagnostic-mystery-diagnosis-remains-elusive-national-institutes-of-health-funded-study-shows
Long Covid Remains Diagnostic Mystery, Dia...
08/13/2024 17:33:12

A recent NIH study reveals no clear diagnostic test for Long Covid, highlighting ongoing challenges in identifying and treating...

this-cognizant-technology-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-wednesday
This Cognizant Technology Analyst Is No Lo...
08/07/2024 12:46:06

deutsche-bank-upgrades-biontech-to-buy-maintains-price-target-to-95
Deutsche Bank Upgrades BioNTech to Buy, Ma...
08/07/2024 09:16:35

Deutsche Bank analyst Emmanuel Papadakis upgrades BioNTech (NASDAQ:BNTX) from Hold to Buy and maintains the price target fro...

Core News & Articles
University Of Pennsylvania Sues BioNTech F...
08/06/2024 18:52:40

- Reuters 

td-cowen-maintains-hold-on-biontech-lowers-price-target-to-85
TD Cowen Maintains Hold on BioNTech, Lower...
08/06/2024 16:48:53

TD Cowen analyst Yaron Werber maintains BioNTech (NASDAQ:BNTX) with a Hold and lowers the price target from $98 to $85.

us-stocks-trim-black-mondays-drops-as-services-gauge-expands-bond-gains-stall-as-traders-reassess-fed-cuts-whats-driving-markets
US Stocks Trim Black Monday's Drops As Ser...
08/05/2024 17:11:24

Global markets are experiencing intense volatility, and while it seemed like a Black Monday for Wall Street was inevitable foll...

biontechs-q2-loss-widens-amid-low-demand-for-its-pfizer-partnered-covid-19-vaccine-increases-rd-spending-on-new-cancer-products
BioNTech's Q2 Loss Widens Amid Low Demand ...
08/05/2024 11:59:26

BioNTech posted a significant Q2 2024 loss of 807.8 million euros. Sales dropped to 128.7 million euros as the demand for COVID...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION